[Maternal drug therapy as a risk factor for congenital heart disease].
D000927:Anticonvulsants / Q000009:adverse effects; D005260:Female; D006330:Heart Defects, Congenital / Q000139:chemically induced*; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D007231:Infant, Newborn; D008094:Lithium / Q000009:adverse effects; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D012306:Risk; D013792:Thalidomide / Q000009:adverse effects
D000927:Anticonvulsants; D006728:Hormones; D013792:Thalidomide; D008094:Lithium
Raskaudenaikainen lääkehoito ja sydämen synnynnäiset kehityshäiriöt.